648 related articles for article (PubMed ID: 33507166)
1. A review of pharmaceutical occurrence and pathways in the aquatic environment in the context of a changing climate and the COVID-19 pandemic.
O'Flynn D; Lawler J; Yusuf A; Parle-McDermott A; Harold D; Mc Cloughlin T; Holland L; Regan F; White B
Anal Methods; 2021 Feb; 13(5):575-594. PubMed ID: 33507166
[TBL] [Abstract][Full Text] [Related]
2. Sources, pathways, and relative risks of contaminants in surface water and groundwater: a perspective prepared for the Walkerton inquiry.
Ritter L; Solomon K; Sibley P; Hall K; Keen P; Mattu G; Linton B
J Toxicol Environ Health A; 2002 Jan; 65(1):1-142. PubMed ID: 11809004
[TBL] [Abstract][Full Text] [Related]
3. Monitoring, sources, receptors, and control measures for three European Union watch list substances of emerging concern in receiving waters - A 20year systematic review.
Tiedeken EJ; Tahar A; McHugh B; Rowan NJ
Sci Total Environ; 2017 Jan; 574():1140-1163. PubMed ID: 27741430
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceuticals in freshwater aquatic environments: A comparison of the African and European challenge.
Fekadu S; Alemayehu E; Dewil R; Van der Bruggen B
Sci Total Environ; 2019 Mar; 654():324-337. PubMed ID: 30448654
[TBL] [Abstract][Full Text] [Related]
5. Selected Pharmaceuticals in Different Aquatic Compartments: Part I-Source, Fate and Occurrence.
Pereira A; Silva L; Laranjeiro C; Lino C; Pena A
Molecules; 2020 Feb; 25(5):. PubMed ID: 32106570
[TBL] [Abstract][Full Text] [Related]
6. Impacts of COVID-19 pandemic on the aquatic environment associated with disinfection byproducts and pharmaceuticals.
Zhang Z; Zhou Y; Han L; Guo X; Wu Z; Fang J; Hou B; Cai Y; Jiang J; Yang Z
Sci Total Environ; 2022 Mar; 811():151409. PubMed ID: 34742986
[TBL] [Abstract][Full Text] [Related]
7. A year-long study of the occurrence and risk of over 140 contaminants of emerging concern in wastewater influent, effluent and receiving waters in the Republic of Ireland.
Rapp-Wright H; Regan F; White B; Barron LP
Sci Total Environ; 2023 Feb; 860():160379. PubMed ID: 36427717
[TBL] [Abstract][Full Text] [Related]
8. Occurrence and ecological risks of pharmaceuticals in a Mediterranean river in Eastern Spain.
Fonseca E; Hernández F; Ibáñez M; Rico A; Pitarch E; Bijlsma L
Environ Int; 2020 Nov; 144():106004. PubMed ID: 32745782
[TBL] [Abstract][Full Text] [Related]
9. A review on pharmaceuticals removal from waters by single and combined biological, membrane filtration and ultrasound systems.
Alfonso-Muniozguren P; Serna-Galvis EA; Bussemaker M; Torres-Palma RA; Lee J
Ultrason Sonochem; 2021 Aug; 76():105656. PubMed ID: 34274706
[TBL] [Abstract][Full Text] [Related]
10. Spatial (bio)accumulation of pharmaceuticals, illicit drugs, plasticisers, perfluorinated compounds and metabolites in river sediment, aquatic plants and benthic organisms.
Wilkinson JL; Hooda PS; Swinden J; Barker J; Barton S
Environ Pollut; 2018 Mar; 234():864-875. PubMed ID: 29248854
[TBL] [Abstract][Full Text] [Related]
11. Ranking and prioritizing pharmaceuticals in the aquatic environment of China.
Li Y; Zhang L; Liu X; Ding J
Sci Total Environ; 2019 Mar; 658():333-342. PubMed ID: 30579191
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and ecotoxicological assessment of pharmaceuticals: Is there a risk for the Mediterranean aquatic environment?
Desbiolles F; Malleret L; Tiliacos C; Wong-Wah-Chung P; Laffont-Schwob I
Sci Total Environ; 2018 Oct; 639():1334-1348. PubMed ID: 29929299
[TBL] [Abstract][Full Text] [Related]
13. Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment.
Zenker A; Cicero MR; Prestinaci F; Bottoni P; Carere M
J Environ Manage; 2014 Jan; 133():378-87. PubMed ID: 24419205
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceuticals and personal care products in the aquatic environment in China: a review.
Bu Q; Wang B; Huang J; Deng S; Yu G
J Hazard Mater; 2013 Nov; 262():189-211. PubMed ID: 24036145
[TBL] [Abstract][Full Text] [Related]
15. Occurrence, distribution, and ecotoxicological risk assessment of selected pharmaceutical compounds in water from Lake Victoria, Uganda.
Nantaba F; Wasswa J; Kylin H; Palm WU; Bouwman H; Kümmerer K
Chemosphere; 2020 Jan; 239():124642. PubMed ID: 31521936
[TBL] [Abstract][Full Text] [Related]
16. Development of a semi-quantitative risk assessment model for evaluating environmental threat posed by the three first EU watch-list pharmaceuticals to urban wastewater treatment plants: An Irish case study.
Tahar A; Tiedeken EJ; Clifford E; Cummins E; Rowan N
Sci Total Environ; 2017 Dec; 603-604():627-638. PubMed ID: 28654878
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceuticals in the aquatic environments: Evidence of emerged threat and future challenges for marine organisms.
Mezzelani M; Gorbi S; Regoli F
Mar Environ Res; 2018 Sep; 140():41-60. PubMed ID: 29859717
[TBL] [Abstract][Full Text] [Related]
18. A One-Health environmental risk assessment of contaminants of emerging concern in London's waterways throughout the SARS-CoV-2 pandemic.
Egli M; Rapp-Wright H; Oloyede O; Francis W; Preston-Allen R; Friedman S; Woodward G; Piel FB; Barron LP
Environ Int; 2023 Oct; 180():108210. PubMed ID: 37778289
[TBL] [Abstract][Full Text] [Related]
19. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
Radjenović J; Petrović M; Barceló D
Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
[TBL] [Abstract][Full Text] [Related]
20. Environmental impact of pharmaceuticals from Portuguese wastewaters: geographical and seasonal occurrence, removal and risk assessment.
Pereira AM; Silva LJ; Meisel LM; Lino CM; Pena A
Environ Res; 2015 Jan; 136():108-19. PubMed ID: 25460627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
